Researchers have developed a test to identify pancreatic cancer in its early stages, according to Barts Cancer Institute, London. A combination of three "signature" proteins were found to be comparatively in much higher levels in urine that could detect patients with stages I-II pancreatic cancer with around 90% accuracy. Till now, the disease was usually diagnosed in its terminal stages.







